Last reviewed · How we verify

Catechin — Competitive Intelligence Brief

Catechin (CIANIDANOL) competitive landscape: 3 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Area: Infectious Disease.

marketed Carbonic anhydrase 7 Infectious Disease Small molecule Live · refreshed every 30 min

Target snapshot

Catechin (CIANIDANOL).

Comparator set (3 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Catechin TARGET CIANIDANOL marketed Carbonic anhydrase 7 1977-01-01
Lozol INDAPAMIDE marketed Thiazide-like Diuretic [EPC] Carbonic anhydrase 7 1983-01-01
Zaroxolyn METOLAZONE I3 Pharms marketed Thiazide-like Diuretic [EPC] Carbonic anhydrase 7 1973-01-01
Combipres Chlortalidone University Hospital Birmingham marketed Thiazide-like Diuretic Carbonic anhydrase 7 1960-01-01

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

Sponsor landscape

No sponsor landscape data.

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Catechin — Competitive Intelligence Brief. https://druglandscape.com/ci/cianidanol. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: